Data / Canada Pharma Snapshot 2020
Up-to-date data and infographics on the Canadian pharma market including an overview of market dynamics,…
AMERICAS
Opinion / The Paradigm Shift Needed for Effective Alzheimer’s Treatments
Holmusk’s Nawal Roy outlines why a cure for Alzheimer’s Disease is the “Holy Grail” of medicine today, the…
Alzheimer's / Aducanumab: On the Regulatory Home Stretch in the USA
In the third of a series of articles chronicling Biogen/Eisai’s Alzheimer’s Disease (AD) treatment…
Opinion / Can We Afford to Pay for Future Cures?
Pharmaceutical innovation is racing ahead of the US health system’s ability to adjust payment models, but…
Opinion / Accumulating Barriers to Care: Double Jeopardy for US Patients
Dan Leonard, Kimberly Westrich, and Brian Sils of the National Pharmaceutical Council examine how a new HHS ruling…
Opinion / US Prescription Drug Pricing: “The Times They Are A Changin”
Ulrich Neumann examines the debate around drug pricing in the US and why it is not going away any time soon. …
BIO 2020 / The FDA’s COVID-19 Shakeup
In a recent virtual town hall meeting hosted by BIO, two key leaders from the US FDA laid out how their…
M&A / Sanofi Buys Principia for USD 3.7 Billion as Part of Specialty Pivot
Sanofi has agreed a deal to buy out its partner, US biotech company Principia Biopharma for USD 3.7 billion in…
Cancer in the USA: A Snapshot
In recent years the US has seen an overall decease in cancer deaths thanks to innovative medicines and treatments.…
In Conversation
Peter L. Saltonstall – President & CEO, National Organization for Rare Disorders (NORD), USA
Peter L Saltonstall, president and CEO of the US National Organization for Rare Disorders (NORD) shares the organization’s key priorities, what makes NORD a unique patient advocacy group in the US, prevailing access and affordability issues for American rare disease patients, and how the country should continue to incentivize a positive R&D environment for orphan drugs and rare diseases. …
Latest Reports
Focus on Colombia
Colombian Tecnoquimicas’ USD 200 Million Manufacturing…
Tecnoquimicas (TQ), the largest domestic player in Colombia’s USD 4.6 billion…
Colombia: The Great Indian Investment Wave
With the onset of universal public healthcare, new types of foreign actors have…
Read more from Colombia >>
Focus on Brazil
Six Trends in the Brazilian OTC Market Post-COVID-19
Panorama Faramceutico’s editorial team look at how the ongoing COVID-19…
Chinese Sinovac Testing COVID-19 Vaccine in Brazil
In the race to develop the world's first COVID-19 vaccine, Brazil - now one of…
Read more from Brazil >>
Focus on Mexico
Pharma Faces: Constanza Losada, Pfizer Mexico
Pfizer, one of the world’s largest pharmaceutical companies, has been active…
Top 10 Pharma Companies in Mexico
A compilation of the top 10 pharmaceutical companies in the Mexican…
Read more from Mexico >>
Focus on USA
The US Regulatory Environment for Biosimilars: Catching up…
As part of our upcoming US Healthcare and Life Sciences Review, we spoke to key…
Aducanumab: On the Regulatory Home Stretch in the USA
In the third of a series of articles chronicling Biogen/Eisai’s Alzheimer’s…
Read more from USA >>
Focus on Canada
Canada Pharma News Roundup September 2020
The latest news from Canadian pharma including deals for J&J’s and…
Drugmakers Push Back Against Canada’s New Pricing…
Pushback from drug companies on Canada’s newest drug pricing regulations has…
Read more from Canada >>
Focus on Puerto Rico
New Puerto Rico Pharma Report January 2020 Out Now
Puerto Rico had to rebuild itself – in many cases quite literally – after…
Company Spotlight: Puerto Rico’s Quality &…
When life sciences companies decide to transfer the production of new drug to…
Read more from Puerto Rico >>
News Roundup / Mexican Pharma: February 2020
Below is a selection of top recent news from Mexican pharma and healthcare, including the healthcare reforms…
Canada / Global Pharma has Reinvented R&D: Will Canadian Start-Ups Lead the Next Phase?
John L. Wallace of Antibe Therapeutics highlights how Canadian innovation stands to put the country at the…
Colombia: The Great Indian Investment Wave
With the onset of universal public healthcare, new types of foreign actors have been spying fresh opportunities to…
The Big Chill: Temperature-Sensitive Pharma Logistics in Brazil
When combining the sheer size of Brazil – the fifth largest country in the world – with its tropical…
Pharma Faces / Constanza Losada, Pfizer Mexico
Pfizer, one of the world’s largest pharmaceutical companies, has been active in Mexico since 1951, and has been…
LATAM / Mexico: Despite Hurdles, Pharma Market Remains Attractive
The United States Trade Representative Office has been engaging with a number of countries, including Mexico, to…